IP Verse

Sagittarius patent opposition analysis

The comprehensive analysis of Sagittarius opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Sagittarius

Stay updated with the latest patent oppositions filed by Sagittarius

Patent NumberTitleApplicantOpposition DateOpposition Company
EP2885312
 - Jun 3, 2026SCORPIO
EP4188327
Combination Therapy For Inhalation AdministrationCHEMO RESEARCH, S.L.Feb 27, 2026SCORPIO
EP3609579
Antimicrobial Compounds From The Genus DelftiaMINISTRY OF HEALTH, STATE OF ISRAELOct 1, 2025SCORPIO
EP3681539
Iron Complex Compounds For Therapeutic UsePHARMACOSMOS HOLDING A/SSep 30, 2025SCORPIO
EP4294810
Process For Preparing High Purity Degree LarotrectinibOLON S.P.A.Jul 16, 2025SCORPIO
EP3090730
Novel Pharmaceutical CompositionNOVARTIS PHARMA AGJan 9, 2025SCORPIO
EP4313945
Crastalline Hydrobromide Salt Of 5-Meo-DmtGH RESEARCH IRELAND LIMITEDDec 4, 2024SCORPIO
EP3227333
Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of DiseasesENGMABMay 16, 2024SCORPIO
EP3752488
Method For Preparing Tert-Butyl N-((1R,2S,5S)-2-((2-((5-Chloropyridin-2-Yl)Amino)-2-Oxoacetyl)Amino)-5-(Dimethylcarbamoyl)Cyclohexyl)CarbamateMOEHS IBÉRICA, S.L.Dec 8, 2023SCORPIO
EP3310760
Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated DisordersARENA PHARMACEUTICALS, INC.Jun 14, 2023SCORPIO

Top clients of Sagittarius

Top companies who are the clients of Sagittarius

CompanyTotal
SCORPIO16
SAGITTARIUS INTELLECTUAL2
STRAWMAN2
SAGITTARIUS1